Proinflammatory cytokine levels in hyperthyroidism

Clinical and Investigative Medicine

Volumn 26, Issue 2, 2003, Pages 58-63

  Senturk, Taskin ^a   Kozaci, L Didem ^a   Kok, Fayat ^a   Kadikoylu, Gurhan ^a   Bolaman, Zahit ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOANALYZER; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TOXIC GOITER;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GOITER; HORMONES; HUMANS; HYPERTHYROIDISM; INFLAMMATION; MALE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE;

EID: 0038000733     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wall RT. Unusual endocrine problems. Anesth Clin North Am 1996;14:471-93.
2. Siddiqui A, Monson JP, Wood DF, Besser GM, Burrin JM. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 1999;84:435-9.
3. Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, et al. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 1997;82:78-81.
4. Toh SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 1985;145:883-6.
5. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990;19:35-63.
6. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD. Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab 1994;78:955-9.
7. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodeling. N Engl J Med 1995;332:305-11.
8. Kurihara N, Bertolini D, Sida T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990;144:4226-30.
9. Ishimi Y, Miyara C. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-303.
10. Tamura T, Udagawa N, Takahashi N. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci U S A 1993;90:11924-8.
11. Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, et al. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996;81:2976-9.
12. Celik I, Akalin S, Erbas T. Serum levels of IL-6 and TNF-α in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 1995;132:668-72.
13. Collin-Osdoby P, Kirch D, Anderson F, Joost O, Dean A, Osdoby P. The chemokine IL-8 as an autocrine inhibitor of osteoclast bone resorptive activity via IL-8 receptors expressed by avian osteoclasts and human osteoclast-like cells [abstract]. J Bone Miner Res 1996;11(Suppl):S357.
14. Fuller K, Owens JM, Chambers TJ. Macrophage inflammatory protein 1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol 1995;154:6065-72.
15. Weetman AP, Ajjan RA, Watson PF. Cytokines and Graves' disease [review]. Baillieres Clin Endocrinol Metab 1997;11:481-97.
16. Dinarello CA. Proinflammatory cytokines. Chest 2000;118:503-8.
17. Weetman AP, Bright-Thomas R, Freeman M. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 1990;127:357-61.
18. Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, et al. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 2000;143:197-202.
19. Aust G, Scherbaum WA. Expression of cytokines in the thyroid: thyrocytes as potential cytokine producers. Exp Clin Endocrinol Diabetes 1996;104(Suppl 4):64-7.
20. Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis and non-autoimmune thyroid disorders determined by quantitative RT-PCR. Thyroid 1996;6:97-106.
21. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-7.
22. Molnar I, Balazs C. High circulating IL-6 level in Graves' ophthalmopathy. Autoimmunity 1997;25:91-6.
23. Komorowski J, Jankiewicz J, Robak T, BlasinskaMorawiec M, Stepien H. Cytokines serum levels as the markers of thyroid activation in Graves' disease. Immunol Lett 1998;60:143-8.
24. Gorschluter M, Bohlen H, Hasenclever D, Diehl V, Tesch H. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Ann Oncol 1995;6:477-82.
25. Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996;14:155-62.
26. Watson PF, Pickerill AP, Davies R, Weetman AP. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 1994;79:355-60.
27. Mysliwiec J, Kretowski A, Szelachowska M, Mikita A, Kinalska I. Serum pro- and anti-inflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids. Rocz Akad Med Bialymst 1999;44:160-9.
28. Wakelkamp IM, Gerding MN, van der Meer JW, Prummel MF, Wiersinga WM. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 2000;121:453-7.
29. Rasmussen AK, Bendtzen K, Feldt-Rasmussen U. Thyrocyte-interleukin-1 interactions. Exp Clin Endocrinol Diabetes 2000;108:67-71.